Asit Parikh - 10 Sep 2024 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Director
Signature
/s/ Molly Henderson, Attorney-in-Fact for Asit Parikh
Issuer symbol
PHAT
Transactions as of
10 Sep 2024
Net transactions value
+$87,900
Form type
4
Filing time
21 Mar 2025, 16:46:34 UTC
Previous filing
24 May 2024
Next filing
16 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Options Exercise $87,900 +7,500 +8.8% $11.72 93,000 10 Sep 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHAT Stock Option (Right to Buy) Options Exercise $0 -7,500 -50% $0.000000 7,500 10 Sep 2024 Common Stock 7,500 $11.72 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount in column 5 shows the amount beneficially owned as of the filing date of this report.